Lucas Bruce 4
4 · Slide Insurance Holdings, Inc. · Filed Mar 9, 2026
Research Summary
AI-generated summary of this filing
Slide Insurance (SLDE) CEO Lucas Bruce Sells Shares
What Happened
- Lucas Bruce, CEO of Slide Insurance Holdings, sold a total of 532,437 shares in open-market transactions between March 5 and March 9, 2026, generating aggregate proceeds of about $9.99M (~$10.0M).
- Mar 5, 2026 — sold 172,644 shares at an average price of $19.37, proceeds $3,344,114.
- Mar 6, 2026 — sold 241,493 shares at an average price of $18.59, proceeds $4,489,355.
- Mar 9, 2026 — sold 118,300 shares at an average price of $18.23, proceeds $2,156,609.
- These were sales (not purchases), commonly considered routine disposition activity rather than an explicit bullish signal.
Key Details
- Transaction dates/prices: Mar 5 ($19.37 avg), Mar 6 ($18.59 avg), Mar 9 ($18.23 avg). Per the filing, individual trade prices across the sales ranged roughly from $17.65 to $19.67 per share.
- Total shares sold: 532,437; total proceeds: ~$9.99M.
- Reported as executed pursuant to a 10b5-1 trading plan adopted by Mr. Bruce on November 21, 2025 (footnote F1).
- Several footnotes note shares held through related entities/trusts (e.g., IIM Holdings II, LLC; Ava and Emma Cloonen Irrevocable Trusts) and spouse-held shares; the reporting person disclaims beneficial ownership of certain shares except to the extent of pecuniary interest.
- Shares owned after the transactions are not provided in the excerpt of the filing you supplied.
- Filing date: Form 4 was filed March 9, 2026 (covers trades Mar 5–9); the filing date matches the last reported trade date, indicating the report appears timely.
Context
- Sales under a pre-established 10b5-1 plan are routine mechanisms insiders use to sell shares on a schedule and are not by themselves proof of a change in view on the company.
- For retail investors, purchases by insiders tend to be more informative than routine sales; note only factual details are reported here — no motivation is stated in the filing.
Insider Transaction Report
Form 4
Lucas Bruce
DirectorChief Executive Officer10% Owner
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-03-05$19.37/sh−172,644$3,344,114→ 39,702,356 total(indirect: By LLC) - Sale
Common Stock
[F1][F4][F3]2026-03-06$18.59/sh−241,493$4,489,355→ 39,460,863 total(indirect: By LLC) - Sale
Common Stock
[F1][F5][F3]2026-03-09$18.23/sh−118,300$2,156,609→ 39,342,563 total(indirect: By LLC)
Holdings
- 1,123,646
Common Stock
- 2,575,837(indirect: By Trust)
Common Stock
- 194,201(indirect: By Spouse)
Common Stock
[F6] - 1,597,341(indirect: By Spouse)
Common Stock
[F7][F8] - 1,925,000(indirect: By Trust)
Common Stock
[F9] - 1,925,000(indirect: By Trust)
Common Stock
[F10]
Footnotes (10)
- [F1]Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2025.
- [F10]Represent shares held through the Ava Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F2]Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $19.11 to $19.67 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F3]The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the Reporting Person. The Reporting Persondisclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F4]Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.31 to $19.23 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F5]Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $17.65 to $18.54 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F6]Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F7]The amount shown reflects the amount owned by the Reporting Person's spouse after the sale of 52,659 shares of common stock between March 5-9, 2026, pursuant to a 10b5-1 trading plan, at prices ranging from $17.65 to $19.67 per share.
- [F8]Represent shares of common stock beneficially owned by the Reporting Person's spouse through Securus Risk Management LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F9]Represent shares held through the Emma Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Signature
/s/ Andy Omiridis, Attorney-in-Fact for Bruce Lucas|2026-03-09